Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
Holders of 5% or more of SANA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sana Biotechnology, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P. | 13G/A | 17.30%46.1M shares | – | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Ra Capital Management, L.P. | 13G | 6.30%18.8M shares | New | May 21, 20261 filing | May 21, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.10%13.6M shares | +0.20 ppfrom 4.90% | Apr 25, 20252 filings | Jan 21, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Sana Biotechnology, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 21, 20269:12 PM ET | Ra Capital Management, L.P.and 3 others | 13G | 6.30%18.8M shares | New | May 14, 2026 | SEC |
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G | 5.10%13.6M shares | +0.20 ppfrom 4.90% | Dec 31, 2025 | SEC |
| Nov 14, 20254:30 PM ET | ARCH Venture Fund IX, L.P.and 14 others | 13G/A | 17.30%46.1M shares | – | Sep 30, 2025 | SEC |
| Apr 25, 20251:00 PM ET | BlackRock, Inc. | 13G/A | 4.90%11.0M shares | –Below 5% | Mar 31, 2025 | SEC |
| Jan 31, 20259:54 AM ET | Vanguard Group Inc | 13G/A | 4.81%10.7M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sana Biotechnology, Inc. shares.
No Form 144 notices for Sana Biotechnology, Inc. are on file.